A study by the European Cancer Anemia Survey (ECAS) was done in 24 European countries to determine the rate of anemia (defined as Hb <12 g/dL) concluded that 75% of patients treated with chemotherapy developed anemia [10]. Here, GSTM1 is linked to anemia.